Chimera Investment (CIM) Gets a Sell Rating from Barclays

Barclays analyst Mark Devries maintained a Sell rating on Chimera Investment (CIMResearch Report) on July 15 and set a price target of $9.00. The company’s shares closed last Friday at $9.11, close to its 52-week low of $7.72.

According to TipRanks.com, Devries is a 5-star analyst with an average return of 12.8% and a 59.0% success rate. Devries covers the Financial sector, focusing on stocks such as Discover Financial Services, Fidelity National Financial, and First American Financial.

Currently, the analyst consensus on Chimera Investment is a Hold with an average price target of $10.00.

See Insiders’ Hot Stocks on TipRanks >>

Chimera Investment’s market cap is currently $2.16B and has a P/E ratio of 12.79.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Chimera Investment Corp. operates as a real estate investment trust. It engages in investing directly or indirectly through its subsidiaries, on a leveraged basis, in a portfolio of mortgage assets. It includes residential mortgage loans, residential mortgage-backed securities, commercial mortgage loans, real estate-related securities, and various other asset classes. The company was founded on June 1, 2007 and is headquartered in New York, NY.

Read More on CIM:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed